{
    "medicine_id": "800396a3dbdc60630aa5ae830d85229d950d5324",
    "platform_id": "719",
    "metadata": {
        "name": "Efavirenz 600 mg Film coated Tablets",
        "composition": "Each film coated tablet contains 600 mg of efavirenz",
        "clinical_particulars": {
            "therapeutic_indications": "Efavirenz is indicated in antiviral combination treatment of human immunodeficiency virus 1 HIV 1 infected adults adolescents and children 3 months of age and older and weighing at least 3 5 kg Efavirenz has not been adequately studied in patients with advanced HIV disease namely in patients with CD4 counts 50 cells mm 3 or after failure of protease inhibitor PI containing regimens Although cross resistance of efavirenz with PIs has not been documented there are at present insufficient data on the efficacy of subsequent use of PI based combination therapy after failure of regimens containing efavirenz For a summary of clinical and pharmacodynamic information see section 5 1",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Patients with severe hepatic impairment Child Pugh Grade C see section 5 2 Co administration with terfenadine astemizole cisapride midazolam triazolam pimozide bepridil or ergot alkaloids for example ergotamine dihydroergotamine ergonovine and methylergonovine because competition for CYP3A4 by efavirenz could result in inhibition of metabolism and create the potential for serious and or life threatening adverse reactions for example cardiac arrhythmias prolonged sedation or respiratory depression see section 4 5 Co administration with elbasvir EBR and grazoprevir GZR due to the potential for significant decreases in plasma concentrations of EBR and GZR see section 4 5 Herbal preparations containing St John s wort Hypericum perforatum due to the risk of decreased plasma concentrations and reduced clinical effects of efavirenz see section 4 5 Patients with severe disturbances of electrolyte balance e g hypokalemia or hypomagnesemia Patients taking drugs that are known to prolong the QTc interval proarrythmic These drugs include",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Cellulose, microcrystalline;Croscarmellose sodium;Hydroxypropyl cellulose;Lactose monohydrate;Silica, colloidal anhydrous;Hypromellose;Macrogol 400;Titanium dioxide (E171);Iron oxide yellow (E172)",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2022-05-12"
    }
}